Menu ≡ ╳ - Home
- News
- COVID-19
- Opinion
- Business
- Regulatory
- Articles
- Intelligence
Categories
Latest Industry Intelligence
- Cancer Research
- Webinars
- Podcasts
- Archive
- Videos
Podcasts
Recipe for success: collaboration in drug discovery
The latest free-to-listen DDW podcast episode is titled “Recipe for success: collaboration in drug discovery”. It covers three articles written for Volume 22, Issue 2 – Spring 2021 of the Drug Discovery World Magazine, narrated by DDW’s Megan Thomas. These articles are titled: “Why collaboration matters and how to make it a success”; “Platform biotechnologies […]
Listen nowMore Episodes
Creating Vaccines, drop by drop
The recent outbreak of COVID-19 has highlighted the need for fast and efficient development and production of vaccines for a whole gamut of pathogens, old and new. Microfluidics technologies can be used to accelerate the vaccine development process in a number of ways, not least in the directed evolution of the strains and host organisms […]
Listen nowThe Reality of Virtual Pharmaceutical Companies
In this episode, we discuss the oxymoronic proposition of a Virtual Pharmaceutical Company (VPC) and the typical adopted business model, as well as provide examples of such companies currently trying to undertake this adventurous task. The vagaries and complexities of bringing a therapeutic drug to market through the Drug Discovery and Development (DDD) process are […]
Listen nowRace To COVID-19 Cure – The Core Model for solving the pandemic crisis (Part 2)
Mitigation of COVID-19 pandemic requires a combination of effective epidemiological policies and the discovery/development of powerful drugs against the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) that causes this disease. This two part article series examines the major initiatives being explored at the public policy level to contain the spread of COVID-19 as well as […]
Listen nowRace To COVID-19 Cure – The Core Model for solving the pandemic crisis (Part 1)
Mitigation of COVID-19 pandemic requires a combination of effective epidemiological policies and the discovery/development of powerful drugs against the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) that causes this disease. This 2 part episode series examines the major initiatives being explored at the public policy level to contain the spread of COVID-19 as well as […]
Listen nowThe COVID-19 antiviral race: we’re all in this together
In response to the COVID-19 pandemic, international scientists from academia and industry have pooled their expertise and resources to identify candidate compounds that inhibit the activity of the SARS-CoV-2 main protease, in order to develop a clinically effective antiviral. The aptly named COVID-19 Moonshot aims to accomplish this task more rapidly than has historically been […]
Listen nowUsing Live-Cell Imaging Systems to Transform Perspectives in Drug Discovery
Live-cell imaging has transformed the study of cell behaviour and function. The technique allows researchers to monitor internal cell structures, interactions and processes in real-time, and over time. In drug discovery, understanding the dynamic processes of cells provides an enhanced picture of drug pharmacology, enabling more reliable predictions of clinical responses earlier in the process. […]
Listen nowFail Early, Fail Fast – A phenotypic rescue approach
New disease targets frequently emerge in literature, but the thorough target validation required to consider these targets for a drug discovery programme is often lacking. In pharmacological or genetic perturbation studies using complex biological assays, undesired off-target effects cannot be easily distinguished from the intended mode of action at the desired target. This is especially […]
Listen nowUnlocking Clinical Trial Data to Uncover New Therapeutic Opportunities
This article discusses opportunities, challenges and best practices in leveraging infrastructure excellence and AI to unlock the value of early or inconclusive clinical trial data. The goal… driving stronger biomarker-based insights and decisions and helping to advance new cures and treatment approaches. As we all know, data is increasingly king in our information-driven world and […]
Listen nowFrom human genome to global genome – why precision medicine must address genetic diversity
The publication of the first human genome sequence more than 15 years ago marked the start of a new era in medicine. In the years since then, researchers have greatly expanded knowledge of gene-disease links and gained a better understanding of the underlying molecular pathways. The first precision therapies, targeted to specific molecular alterations, are […]
Listen nowHow Artificial Intelligence is Transforming Drug Design
AI could create a streamlined, automated approach to drug discovery, trawling vast datasets to identify targets, find candidate molecules and predict synthesis routes. Getting there will require significant vision, but we are already seeing exciting examples of AI helping direct research and reduce discovery times. We discuss the short and long term potential of AI […]
Listen now